A Phase One Open-Label Single-Radiolabeled Dose Study To Investigate The Absorption, Metabolism And Excretion Of [14C]PF-02341066 In Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2012
At a glance
- Drugs Crizotinib (Primary)
- Indications Neuroblastoma; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- 25 Oct 2011 Primary endpoints identified as reported by ClinicalTrials.gov.
- 19 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.